The future of Alzheimer's disease risk prediction: a systematic review.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published Date:

Abstract

BACKGROUND: Alzheimer's disease is the most prevalent kind of age-associated dementia among older adults globally. Traditional diagnostic models for predicting Alzheimer's disease risks primarily rely on demographic and clinical data to develop policies and assess probabilities. However, recent advancements in machine learning (ML) and other artificial intelligence (AI) have shown promise in developing personalized risk models. These models use specific patient data from medical imaging and related reports. In this systematic review, different studies comprehensively examined the use of ML in magnetic resonance imaging (MRI), genetics, radiomics, and medical data for Alzheimer's disease risk assessment. I highlighted the results of our rigorous analysis of this research and emphasized the exciting potential of ML methods for Alzheimer's disease risk prediction. We also looked at current research projects and possible uses of AI-driven methods to enhance Alzheimer's disease risk prediction and enable more efficient investigating and individualized risk mitigation strategies.

Authors

  • Sophia Nazir
    Nanomaterials & Devices (NMD) Laboratory, School of Computing, Electronics and Mathematics , Plymouth University, Devon, PL4 8 AA, UK. sophia.nazir@plymouth.ac.uk.